Q3 2011
Released Nov 14, 2011, after the close
10-Q filed Nov 14, 2011, 45 days after period end · 0001144204-11-064400
Q3 2011 · 10-Q
Revenue$407.00K$407.00K −34.6% vs Q3 2010−36.1% vs Q2 2011
Net Income-$413.00K-$413.00K N/M vs Q3 2010N/M vs Q2 2011
EPS Diluted-$0.04-$0.04 N/M vs Q3 2010N/M vs Q2 2011
Gross Profit$309,000+2.0%
Operating Income-$425,000N/M
Operating Cash Flowderived$409,000+424.4%
Margins · derived
Gross margin75.9%+27.2 pt vs Q3 2010
Operating margin-104.4%−41.2 pt vs Q3 2010
Net margin-101.5%−41.2 pt vs Q3 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $407.00K | $622.00K |
| Net Income | -$413.00K | -$375.00K |
| EPS Diluted | -$0.04 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR